ATLANTA, Nov. 5, 2010 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc., (Nasdaq:ALIM) (“Alimera”), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today accepted the 2010 Southeast BIO (SEBIO) Deal of the Year: Strategic Transaction award at a ceremony held at the conclusion of the organization’s 12th Annual Investor Forum. The SEBIO Annual Investor Forum is the region’s premier life sciences venture capital conference and attracts an estimated 400 attendees. Rick Eiswirth, Alimera’s chief operating officer and chief financial officer, accepted the award on behalf of the company.
